1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Empagliflozin API Consumption 2016-2026 2.1.2 Empagliflozin API Consumption CAGR by Region 2.2 Empagliflozin API Segment by Type 2.2.1 Purity≥98% 2.2.2 Purity<98% 2.3 Empagliflozin API Sales by Type 2.3.1 Global Empagliflozin API Sales Market Share by Type (2016-2021) 2.3.2 Global Empagliflozin API Revenue and Market Share by Type (2016-2021) 2.3.3 Global Empagliflozin API Sale Price by Type (2016-2021) 2.4 Empagliflozin API Segment by Application 2.4.1 Empagliflozin Tablets 2.4.2 Others 2.5 Empagliflozin API Sales by Application 2.5.1 Global Empagliflozin API Sale Market Share by Application (2016-2021) 2.5.2 Global Empagliflozin API Revenue and Market Share by Application (2016-2021) 2.5.3 Global Empagliflozin API Sale Price by Application (2016-2021) 3 Global Empagliflozin API by Company 3.1 Global Empagliflozin API Sales Market Share by Company 3.1.1 Global Empagliflozin API Sales by Company (2019-2021) 3.1.2 Global Empagliflozin API Sales Market Share by Company (2019-2021) 3.2 Global Empagliflozin API Revenue Market Share by Company 3.2.1 Global Empagliflozin API Revenue by Company (2019-2021) 3.2.2 Global Empagliflozin API Revenue Market Share by Company (2019-2021) 3.3 Global Empagliflozin API Sale Price by Company 3.4 Global Manufacturers Empagliflozin API Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Empagliflozin API Product Location Distribution 3.4.2 Players Empagliflozin API Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 Empagliflozin API by Region 4.1 Global Empagliflozin API by Region 4.1.1 Global Empagliflozin API Sales by Region 4.1.2 Global Empagliflozin API Revenue by Region 4.2 Americas Empagliflozin API Sales Growth 4.3 APAC Empagliflozin API Sales Growth 4.4 Europe Empagliflozin API Sales Growth 4.5 Middle East & Africa Empagliflozin API Sales Growth 5 Americas 5.1 Americas Empagliflozin API Sales by Country 5.1.1 Americas Empagliflozin API Sales by Country (2016-2021) 5.1.2 Americas Empagliflozin API Revenue by Country (2016-2021) 5.2 Americas Empagliflozin API Sales by Type 5.3 Americas Empagliflozin API Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Empagliflozin API Sales by Region 6.1.1 APAC Empagliflozin API Sales by Region (2016-2021) 6.1.2 APAC Empagliflozin API Revenue by Region (2016-2021) 6.2 APAC Empagliflozin API Sales by Type 6.3 APAC Empagliflozin API Sales by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Empagliflozin API by Country 7.1.1 Europe Empagliflozin API Sales by Country (2016-2021) 7.1.2 Europe Empagliflozin API Revenue by Country (2016-2021) 7.2 Europe Empagliflozin API Sales by Type 7.3 Europe Empagliflozin API Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Empagliflozin API by Country 8.1.1 Middle East & Africa Empagliflozin API Sales by Country (2016-2021) 8.1.2 Middle East & Africa Empagliflozin API Revenue by Country (2016-2021) 8.2 Middle East & Africa Empagliflozin API Sales by Type 8.3 Middle East & Africa Empagliflozin API Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Empagliflozin API Distributors 10.3 Empagliflozin API Customer 11 Global Empagliflozin API Market Forecast 11.1 Global Empagliflozin API Forecast by Region 11.1.1 Global Empagliflozin API Forecast by Regions (2021-2026) 11.2.2 Global Empagliflozin API Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Empagliflozin API Forecast by Type 11.7 Global Empagliflozin API Forecast by Application 12 Key Players Analysis 12.1 Piramal Enterprises Limited 12.1.1 Piramal Enterprises Limited Company Information 12.1.2 Piramal Enterprises Limited Empagliflozin API Product Offered 12.1.3 Piramal Enterprises Limited Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 Piramal Enterprises Limited Main Business Overview 12.1.5 Piramal Enterprises Limited Latest Developments 12.2 Metrochem API Private Limited 12.2.1 Metrochem API Private Limited Company Information 12.2.2 Metrochem API Private Limited Empagliflozin API Product Offered 12.2.3 Metrochem API Private Limited Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 Metrochem API Private Limited Main Business Overview 12.2.5 Metrochem API Private Limited Latest Developments 12.3 ZCL Chemicals Limited 12.3.1 ZCL Chemicals Limited Company Information 12.3.2 ZCL Chemicals Limited Empagliflozin API Product Offered 12.3.3 ZCL Chemicals Limited Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 ZCL Chemicals Limited Main Business Overview 12.3.5 ZCL Chemicals Limited Latest Developments 12.4 Dr. Reddy's Laboratories 12.4.1 Dr. Reddy's Laboratories Company Information 12.4.2 Dr. Reddy's Laboratories Empagliflozin API Product Offered 12.4.3 Dr. Reddy's Laboratories Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 Dr. Reddy's Laboratories Main Business Overview 12.4.5 Dr. Reddy's Laboratories Latest Developments 12.5 Teva Pharmaceutical Industries Ltd. 12.5.1 Teva Pharmaceutical Industries Ltd. Company Information 12.5.2 Teva Pharmaceutical Industries Ltd. Empagliflozin API Product Offered 12.5.3 Teva Pharmaceutical Industries Ltd. Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 Teva Pharmaceutical Industries Ltd. Main Business Overview 12.5.5 Teva Pharmaceutical Industries Ltd. Latest Developments 12.6 Sun Pharmaceutical Industries Ltd. 12.6.1 Sun Pharmaceutical Industries Ltd. Company Information 12.6.2 Sun Pharmaceutical Industries Ltd. Empagliflozin API Product Offered 12.6.3 Sun Pharmaceutical Industries Ltd. Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.6.4 Sun Pharmaceutical Industries Ltd. Main Business Overview 12.6.5 Sun Pharmaceutical Industries Ltd. Latest Developments 12.7 Hikal 12.7.1 Hikal Company Information 12.7.2 Hikal Empagliflozin API Product Offered 12.7.3 Hikal Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.7.4 Hikal Main Business Overview 12.7.5 Hikal Latest Developments 12.8 Morepen Laboratories 12.8.1 Morepen Laboratories Company Information 12.8.2 Morepen Laboratories Empagliflozin API Product Offered 12.8.3 Morepen Laboratories Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.8.4 Morepen Laboratories Main Business Overview 12.8.5 Morepen Laboratories Latest Developments 12.9 Zhejiang Huahai Pharmaceutial. Co., Ltd. 12.9.1 Zhejiang Huahai Pharmaceutial. Co., Ltd. Company Information 12.9.2 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Product Offered 12.9.3 Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.9.4 Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business Overview 12.9.5 Zhejiang Huahai Pharmaceutial. Co., Ltd. Latest Developments 12.10 Lupin Ltd 12.10.1 Lupin Ltd Company Information 12.10.2 Lupin Ltd Empagliflozin API Product Offered 12.10.3 Lupin Ltd Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.10.4 Lupin Ltd Main Business Overview 12.10.5 Lupin Ltd Latest Developments 12.11 Biocon Limited 12.11.1 Biocon Limited Company Information 12.11.2 Biocon Limited Empagliflozin API Product Offered 12.11.3 Biocon Limited Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.11.4 Biocon Limited Main Business Overview 12.11.5 Biocon Limited Latest Developments 12.12 Mehta API Pvt. Ltd 12.12.1 Mehta API Pvt. Ltd Company Information 12.12.2 Mehta API Pvt. Ltd Empagliflozin API Product Offered 12.12.3 Mehta API Pvt. Ltd Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.12.4 Mehta API Pvt. Ltd Main Business Overview 12.12.5 Mehta API Pvt. Ltd Latest Developments 12.13 Danesh Kimia Pharmed 12.13.1 Danesh Kimia Pharmed Company Information 12.13.2 Danesh Kimia Pharmed Empagliflozin API Product Offered 12.13.3 Danesh Kimia Pharmed Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.13.4 Danesh Kimia Pharmed Main Business Overview 12.13.5 Danesh Kimia Pharmed Latest Developments 12.14 Shandong Haohong Biotechnology Co., Ltd. 12.14.1 Shandong Haohong Biotechnology Co., Ltd. Company Information 12.14.2 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Product Offered 12.14.3 Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.14.4 Shandong Haohong Biotechnology Co., Ltd. Main Business Overview 12.14.5 Shandong Haohong Biotechnology Co., Ltd. Latest Developments 12.15 Boryung Pharmaceutical Co., Ltd 12.15.1 Boryung Pharmaceutical Co., Ltd Company Information 12.15.2 Boryung Pharmaceutical Co., Ltd Empagliflozin API Product Offered 12.15.3 Boryung Pharmaceutical Co., Ltd Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.15.4 Boryung Pharmaceutical Co., Ltd Main Business Overview 12.15.5 Boryung Pharmaceutical Co., Ltd Latest Developments 12.16 Ami Lifesciences 12.16.1 Ami Lifesciences Company Information 12.16.2 Ami Lifesciences Empagliflozin API Product Offered 12.16.3 Ami Lifesciences Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.16.4 Ami Lifesciences Main Business Overview 12.16.5 Ami Lifesciences Latest Developments 12.17 Jiangsu Yutian Pharmaceutical Co., Ltd. 12.17.1 Jiangsu Yutian Pharmaceutical Co., Ltd. Company Information 12.17.2 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Product Offered 12.17.3 Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.17.4 Jiangsu Yutian Pharmaceutical Co., Ltd. Main Business Overview 12.17.5 Jiangsu Yutian Pharmaceutical Co., Ltd. Latest Developments 12.18 SGMR Pharmaceuticals 12.18.1 SGMR Pharmaceuticals Company Information 12.18.2 SGMR Pharmaceuticals Empagliflozin API Product Offered 12.18.3 SGMR Pharmaceuticals Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.18.4 SGMR Pharmaceuticals Main Business Overview 12.18.5 SGMR Pharmaceuticals Latest Developments 12.19 Kopran Limited 12.19.1 Kopran Limited Company Information 12.19.2 Kopran Limited Empagliflozin API Product Offered 12.19.3 Kopran Limited Empagliflozin API Sales, Revenue, Price and Gross Margin (2019-2021) 12.19.4 Kopran Limited Main Business Overview 12.19.5 Kopran Limited Latest Developments 13 Research Findings and Conclusion

List of Tables Table 1. Empagliflozin API Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Purity≥98% Table 3. Major Players of Purity<98% Table 4. Global Empagliflozin API Sales by Type (2016-2021) & (Ton) Table 5. Global Empagliflozin API Sales Market Share by Type (2016-2021) Table 6. Global Empagliflozin API Revenue by Type (2016-2021) & ($ million) Table 7. Global Empagliflozin API Revenue Market Share by Type (2016-2021) Table 8. Global Empagliflozin API Sale Price by Type (2016-2021) Table 9. Global Empagliflozin API Sales by Application (2016-2021) & (Ton) Table 10. Global Empagliflozin API Sales Market Share by Application (2016-2021) Table 11. Global Empagliflozin API Value by Application (2016-2021) Table 12. Global Empagliflozin API Revenue Market Share by Application (2016-2021) Table 13. Global Empagliflozin API Sale Price by Application (2016-2021) Table 14. Global Empagliflozin API Sales by Company (2019-2021) & (Ton) Table 15. Global Empagliflozin API Sales Market Share by Company (2019-2021) Table 16. Global Empagliflozin API Revenue by Company (2019-2021) ($ Millions) Table 17. Global Empagliflozin API Revenue Market Share by Company (2019-2021) Table 18. Global Empagliflozin API Sale Price by Company (2019-2021) Table 19. Key Manufacturers Empagliflozin API Producing Area Distribution and Sales Area Table 20. Players Empagliflozin API Products Offered Table 21. Empagliflozin API Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Empagliflozin API Sales by Region (2016-2021) (Ton) Table 25. Global Empagliflozin API Sales Market Share by Region (2016-2021) Table 26. Global Empagliflozin API Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Empagliflozin API Revenue Market Share by Region (2016-2021) Table 28. Americas Empagliflozin API Sales by Country (2016-2021) & (Ton) Table 29. Americas Empagliflozin API Sales Market Share by Country (2016-2021) Table 30. Americas Empagliflozin API Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Empagliflozin API Revenue Market Share by Country (2016-2021) Table 32. Americas Empagliflozin API Sales by Type (2016-2021) & (Ton) Table 33. Americas Empagliflozin API Sales Market Share by Type (2016-2021) Table 34. Americas Empagliflozin API Sales by Application (2016-2021) & (Ton) Table 35. Americas Empagliflozin API Sales Market Share by Application (2016-2021) Table 36. APAC Empagliflozin API Sales by Region (2016-2021) & (Ton) Table 37. APAC Empagliflozin API Sales Market Share by Region (2016-2021) Table 38. APAC Empagliflozin API Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Empagliflozin API Revenue Market Share by Region (2016-2021) Table 40. APAC Empagliflozin API Sales by Type (2016-2021) & (Ton) Table 41. APAC Empagliflozin API Sales Market Share by Type (2016-2021) Table 42. APAC Empagliflozin API Sales by Application (2016-2021) & (Ton) Table 43. APAC Empagliflozin API Sales Market Share by Application (2016-2021) Table 44. Europe Empagliflozin API Sales by Country (2016-2021) & (Ton) Table 45. Europe Empagliflozin API Sales Market Share by Country (2016-2021) Table 46. Europe Empagliflozin API Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Empagliflozin API Revenue Market Share by Country (2016-2021) Table 48. Europe Empagliflozin API Sales by Type (2016-2021) & (Ton) Table 49. Europe Empagliflozin API Sales Market Share by Type (2016-2021) Table 50. Europe Empagliflozin API Sales by Application (2016-2021) & (Ton) Table 51. Europe Empagliflozin API Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Empagliflozin API Sales by Country (2016-2021) & (Ton) Table 53. Middle East & Africa Empagliflozin API Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Empagliflozin API Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Empagliflozin API Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Empagliflozin API Sales by Type (2016-2021) & (Ton) Table 57. Middle East & Africa Empagliflozin API Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Empagliflozin API Sales by Application (2016-2021) & (Ton) Table 59. Middle East & Africa Empagliflozin API Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Empagliflozin API Table 61. Key Application and Potential Industries of Empagliflozin API Table 62. Key Challenges of Empagliflozin API Table 63. Key Trends of Empagliflozin API Table 64. Empagliflozin API Distributors List Table 65. Empagliflozin API Customer List Table 66. Global Empagliflozin API Sales Forecast by Region (2021-2026) & (Ton) Table 67. Global Empagliflozin API Consumption Market Forecast by Region Table 68. Global Empagliflozin API Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Empagliflozin API Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Empagliflozin API Sales Forecast by Country (2021-2026) & (Ton) Table 71. Americas Empagliflozin API Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Empagliflozin API Sales Forecast by Region (2021-2026) & (Ton) Table 73. APAC Empagliflozin API Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Empagliflozin API Sales Forecast by Country (2021-2026) & (Ton) Table 75. Europe Empagliflozin API Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Empagliflozin API Sales Forecast by Country (2021-2026) & (Ton) Table 77. Middle East & Africa Empagliflozin API Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Empagliflozin API Sales Forecast by Type (2021-2026) & (Ton) Table 79. Global Empagliflozin API Sales Market Share Forecast by Type (2021-2026) Table 80. Global Empagliflozin API Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Empagliflozin API Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Empagliflozin API Sales Forecast by Application (2021-2026) & (Ton) Table 83. Global Empagliflozin API Sales Market Share Forecast by Application (2021-2026) Table 84. Global Empagliflozin API Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Empagliflozin API Revenue Market Share Forecast by Application (2021-2026) Table 86. Piramal Enterprises Limited Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 87. Piramal Enterprises Limited Empagliflozin API Product Offered Table 88. Piramal Enterprises Limited Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 89. Piramal Enterprises Limited Main Business Table 90. Piramal Enterprises Limited Latest Developments Table 91. Metrochem API Private Limited Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 92. Metrochem API Private Limited Empagliflozin API Product Offered Table 93. Metrochem API Private Limited Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 94. Metrochem API Private Limited Main Business Table 95. Metrochem API Private Limited Latest Developments Table 96. ZCL Chemicals Limited Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 97. ZCL Chemicals Limited Empagliflozin API Product Offered Table 98. ZCL Chemicals Limited Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 99. ZCL Chemicals Limited Main Business Table 100. ZCL Chemicals Limited Latest Developments Table 101. Dr. Reddy's Laboratories Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 102. Dr. Reddy's Laboratories Empagliflozin API Product Offered Table 103. Dr. Reddy's Laboratories Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 104. Dr. Reddy's Laboratories Main Business Table 105. Dr. Reddy's Laboratories Latest Developments Table 106. Teva Pharmaceutical Industries Ltd. Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 107. Teva Pharmaceutical Industries Ltd. Empagliflozin API Product Offered Table 108. Teva Pharmaceutical Industries Ltd. Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 109. Teva Pharmaceutical Industries Ltd. Main Business Table 110. Teva Pharmaceutical Industries Ltd. Latest Developments Table 111. Sun Pharmaceutical Industries Ltd. Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 112. Sun Pharmaceutical Industries Ltd. Empagliflozin API Product Offered Table 113. Sun Pharmaceutical Industries Ltd. Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 114. Sun Pharmaceutical Industries Ltd. Main Business Table 115. Sun Pharmaceutical Industries Ltd. Latest Developments Table 116. Hikal Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 117. Hikal Empagliflozin API Product Offered Table 118. Hikal Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 119. Hikal Main Business Table 120. Hikal Latest Developments Table 121. Morepen Laboratories Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 122. Morepen Laboratories Empagliflozin API Product Offered Table 123. Morepen Laboratories Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 124. Morepen Laboratories Main Business Table 125. Morepen Laboratories Latest Developments Table 126. Zhejiang Huahai Pharmaceutial. Co., Ltd. Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 127. Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Product Offered Table 128. Zhejiang Huahai Pharmaceutial. Co., Ltd. Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 129. Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business Table 130. Zhejiang Huahai Pharmaceutial. Co., Ltd. Latest Developments Table 131. Lupin Ltd Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 132. Lupin Ltd Empagliflozin API Product Offered Table 133. Lupin Ltd Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 134. Lupin Ltd Main Business Table 135. Lupin Ltd Latest Developments Table 136. Biocon Limited Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 137. Biocon Limited Empagliflozin API Product Offered Table 138. Biocon Limited Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 139. Biocon Limited Main Business Table 140. Biocon Limited Latest Developments Table 141. Mehta API Pvt. Ltd Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 142. Mehta API Pvt. Ltd Empagliflozin API Product Offered Table 143. Mehta API Pvt. Ltd Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 144. Mehta API Pvt. Ltd Main Business Table 145. Mehta API Pvt. Ltd Latest Developments Table 146. Danesh Kimia Pharmed Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 147. Danesh Kimia Pharmed Empagliflozin API Product Offered Table 148. Danesh Kimia Pharmed Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 149. Danesh Kimia Pharmed Main Business Table 150. Danesh Kimia Pharmed Latest Developments Table 151. Shandong Haohong Biotechnology Co., Ltd. Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 152. Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Product Offered Table 153. Shandong Haohong Biotechnology Co., Ltd. Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 154. Shandong Haohong Biotechnology Co., Ltd. Main Business Table 155. Shandong Haohong Biotechnology Co., Ltd. Latest Developments Table 156. Boryung Pharmaceutical Co., Ltd Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 157. Boryung Pharmaceutical Co., Ltd Empagliflozin API Product Offered Table 158. Boryung Pharmaceutical Co., Ltd Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 159. Boryung Pharmaceutical Co., Ltd Main Business Table 160. Boryung Pharmaceutical Co., Ltd Latest Developments Table 161. Ami Lifesciences Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 162. Ami Lifesciences Empagliflozin API Product Offered Table 163. Ami Lifesciences Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 164. Ami Lifesciences Main Business Table 165. Ami Lifesciences Latest Developments Table 166. Jiangsu Yutian Pharmaceutical Co., Ltd. Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 167. Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Product Offered Table 168. Jiangsu Yutian Pharmaceutical Co., Ltd. Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 169. Jiangsu Yutian Pharmaceutical Co., Ltd. Main Business Table 170. Jiangsu Yutian Pharmaceutical Co., Ltd. Latest Developments Table 171. SGMR Pharmaceuticals Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 172. SGMR Pharmaceuticals Empagliflozin API Product Offered Table 173. SGMR Pharmaceuticals Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 174. SGMR Pharmaceuticals Main Business Table 175. SGMR Pharmaceuticals Latest Developments Table 176. Kopran Limited Basic Information, Empagliflozin API Manufacturing Base, Sales Area and Its Competitors Table 177. Kopran Limited Empagliflozin API Product Offered Table 178. Kopran Limited Empagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E) Table 179. Kopran Limited Main Business Table 180. Kopran Limited Latest Developments List of Figures Figure 1. Picture of Empagliflozin API Figure 2. Empagliflozin API Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Empagliflozin API Sales Growth Rate 2016-2026 (Ton) Figure 7. Global Empagliflozin API Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Empagliflozin API Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Purity≥98% Figure 10. Product Picture of Purity<98% Figure 11. Global Empagliflozin API Sales Market Share by Type in 2020 Figure 12. Global Empagliflozin API Revenue Market Share by Type (2016-2021) Figure 13. Empagliflozin API Consumed in Empagliflozin Tablets Figure 14. Global Empagliflozin API Market: Empagliflozin Tablets (2016-2021) & (Ton) Figure 15. Empagliflozin API Consumed in Others Figure 16. Global Empagliflozin API Market: Others (2016-2021) & (Ton) Figure 17. Global Empagliflozin API Sales Market Share by Application (2016-2021) Figure 18. Global Empagliflozin API Revenue Market Share by Application in 2020 Figure 19. Empagliflozin API Revenue Market by Company in 2020 ($ Million) Figure 20. Global Empagliflozin API Revenue Market Share by Company in 2020 Figure 21. Global Empagliflozin API Sales Market Share by Regions (2016-2021) Figure 22. Global Empagliflozin API Revenue Market Share by Region in 2020 Figure 23. Americas Empagliflozin API Sales 2016-2021 (Ton) Figure 24. Americas Empagliflozin API Revenue 2016-2021 ($ Millions) Figure 25. APAC Empagliflozin API Sales 2016-2021 (Ton) Figure 26. APAC Empagliflozin API Revenue 2016-2021 ($ Millions) Figure 27. Europe Empagliflozin API Sales 2016-2021 (Ton) Figure 28. Europe Empagliflozin API Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Empagliflozin API Sales 2016-2021 (Ton) Figure 30. Middle East & Africa Empagliflozin API Revenue 2016-2021 ($ Millions) Figure 31. Americas Empagliflozin API Sales Market Share by Country in 2020 Figure 32. Americas Empagliflozin API Revenue Market Share by Country in 2020 Figure 33. Americas Empagliflozin API Sales Market Share by Type in 2020 Figure 34. Americas Empagliflozin API Sales Market Share by Application in 2020 Figure 35. United States Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Empagliflozin API Sales Market Share by Region in 2020 Figure 40. APAC Empagliflozin API Revenue Market Share by Regions in 2020 Figure 41. APAC Empagliflozin API Sales Market Share by Type in 2020 Figure 42. APAC Empagliflozin API Sales Market Share by Application in 2020 Figure 43. China Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 47. India Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Empagliflozin API Sales Market Share by Country in 2020 Figure 50. Europe Empagliflozin API Revenue Market Share by Country in 2020 Figure 51. Europe Empagliflozin API Sales Market Share by Type in 2020 Figure 52. Europe Empagliflozin API Sales Market Share by Application in 2020 Figure 53. Germany Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 54. France Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Empagliflozin API Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Empagliflozin API Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Empagliflozin API Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Empagliflozin API Sales Market Share by Application in 2020 Figure 62. Egypt Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Empagliflozin API Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles